Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parkinson's Disease

  Free Subscription


Articles published in Neurosci Lett

Retrieve available abstracts of 252 articles:
HTML format



Single Articles


    July 2021
  1. SALJUQI M, Ghaderyan P
    A novel method based on matching pursuit decomposition of gait signals for Parkinson's disease, Amyotrophic lateral sclerosis and Huntington's disease detection.
    Neurosci Lett. 2021 Jul 10:136107. doi: 10.1016/j.neulet.2021.136107.
    PubMed     Abstract available


    June 2021
  2. BAI X, Dong Q, Zhao L, Yao Y, et al
    microRNA-106b-containing extracellular vesicles affect autophagy of neurons by regulating CDKN2B in Parkinson's disease.
    Neurosci Lett. 2021 Jun 30:136094. doi: 10.1016/j.neulet.2021.136094.
    PubMed     Abstract available


  3. DA SILVA WAB, Ferreira Oliveira K, Caroline Vitorino L, Ferreira Romao L, et al
    Physical exercise increases the production of tyrosine hydroxylase and CDNF in the spinal cord of a Parkinson's disease mouse model.
    Neurosci Lett. 2021 Jun 25:136089. doi: 10.1016/j.neulet.2021.136089.
    PubMed     Abstract available


  4. SUN D, Wu X, Xia Y, Wu F, et al
    Differentiating Parkinson's Disease Motor Subtypes: A Radiomics Analysis Based on Deep Gray Nuclear Lesion and White Matter.
    Neurosci Lett. 2021 Jun 23:136083. doi: 10.1016/j.neulet.2021.136083.
    PubMed     Abstract available


  5. YIN K, Zhou C, Yin L, Zhu Y, et al
    Resting-state functional magnetic resonance imaging of the cerebellar vermis in patients with Parkinson's disease and visuospatial disorder.
    Neurosci Lett. 2021;760:136082.
    PubMed     Abstract available


  6. XU X, He X, Ma S, Li M, et al
    Nurr1 downregulation is caused by CREB inactivation in a Parkinson's disease mouse model.
    Neurosci Lett. 2021;759:136045.
    PubMed     Abstract available


  7. NIYOMRAT K, Cheaha D, Nukitram J, Kumarnsit E, et al
    Locomotor activity and resting local field potential oscillatory rhythms of 6-OHDA mouse model of Parkinson's disease in response to acute and repeated treatments with L-dopa.
    Neurosci Lett. 2021 Jun 4:136007. doi: 10.1016/j.neulet.2021.136007.
    PubMed     Abstract available


    May 2021
  8. LI N, Suo X, Zhang J, Lei D, et al
    Disrupted functional brain network topology in Parkinson's disease patients with freezing of gait.
    Neurosci Lett. 2021 May 20:135970. doi: 10.1016/j.neulet.2021.135970.
    PubMed     Abstract available


  9. TAKAHASHI K, Iwaoka K, Takahashi K, Suzuki Y, et al
    Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson's disease and progressive supranuclear palsy.
    Neurosci Lett. 2021 May 20:135975. doi: 10.1016/j.neulet.2021.135975.
    PubMed     Abstract available


  10. RONG Z, Shen F, Wang Y, Sun L, et al
    Phosphorylated alpha-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
    Neurosci Lett. 2021;756:135964.
    PubMed     Abstract available


    April 2021
  11. VENKATESAN D, Iyer M, S RW, G L, et al
    The association between multiple risk factors, clinical correlations and molecular insights in Parkinson's disease patients from Tamil Nadu population, India.
    Neurosci Lett. 2021;755:135903.
    PubMed     Abstract available


  12. SALAS-LEAL AC, Salas-Pacheco SM, Gavilan-Ceniceros JAP, Castellanos-Juarez FX, et al
    alpha-syn and SNP rs356219 as a potential biomarker in blood for Parkinson's disease in Mexican Mestizos.
    Neurosci Lett. 2021;754:135901.
    PubMed     Abstract available


  13. ZHANG L, He Y, Lei K, Fang Z, et al
    Gene expression profiling of early Parkinson's disease patient reveals redox homeostasis.
    Neurosci Lett. 2021;753:135893.
    PubMed     Abstract available


  14. BAI X, Liu X, Li X, Li W, et al
    Association between VPS13C rs2414739 polymorphism and Parkinson's disease risk: A meta-analysis.
    Neurosci Lett. 2021 Apr 7:135879. doi: 10.1016/j.neulet.2021.135879.
    PubMed     Abstract available


  15. RAJ K, Kaur P, Gupta GD, Singh S, et al
    Metals associated neurodegeneration in Parkinson's disease: Insight to physiological, pathological mechanisms and management.
    Neurosci Lett. 2021;753:135873.
    PubMed     Abstract available


  16. KAKOTY V, K C S, Dubey SK, Yang CH, et al
    The gut-brain connection in the pathogenicity of Parkinson disease: Putative role of autophagy.
    Neurosci Lett. 2021;753:135865.
    PubMed     Abstract available


  17. WERNICK AI, Walton RL, Soto-Beasley AI, Koga S, et al
    Investigating ELOVL7 coding variants in multiple system atrophy.
    Neurosci Lett. 2021;749:135723.
    PubMed     Abstract available


    March 2021
  18. NAUSHAD SM, Hussain T, Alrokayan S, Kutala VK, et al
    Alpha synuclein (SNCA) rs7684318 variant contributes to Parkinson's disease risk by altering transcription factor binding related with Notch and Wnt signaling.
    Neurosci Lett. 2021 Mar 8:135802. doi: 10.1016/j.neulet.2021.135802.
    PubMed     Abstract available


    February 2021
  19. KAKOTY V, Sarathlal KC, Dubey SK, Yang CH, et al
    Lentiviral mediated gene delivery as an effective therapeutic approach for Parkinson disease.
    Neurosci Lett. 2021 Feb 23:135769. doi: 10.1016/j.neulet.2021.135769.
    PubMed     Abstract available


  20. SHARMA T, Kaur D, Grewal AK, Singh TG, et al
    Therapies modulating insulin resistance in Parkinson's disease: A cross talk.
    Neurosci Lett. 2021 Feb 18:135754. doi: 10.1016/j.neulet.2021.135754.
    PubMed     Abstract available


  21. SIOKAS V, Arseniou S, Aloizou AM, Tsouris Z, et al
    CD33 rs3865444 as a risk factor for Parkinson's disease.
    Neurosci Lett. 2021 Feb 11:135709. doi: 10.1016/j.neulet.2021.135709.
    PubMed     Abstract available


    January 2021
  22. GUO W, Jin W, Li N, Gao J, et al
    Brain activity alterations in patients with Parkinson's disease with cognitive impairment based on resting-state functional MRI.
    Neurosci Lett. 2021 Jan 27:135672. doi: 10.1016/j.neulet.2021.135672.
    PubMed     Abstract available


  23. LEE SH, Han YT, Cha DS
    Neuroprotective effect of damaurone D in a C. elegans model of Parkinson's Disease.
    Neurosci Lett. 2021 Jan 19:135623. doi: 10.1016/j.neulet.2021.135623.
    PubMed     Abstract available


  24. ZHANG L, Yang H
    Promotive effects of tetrahydroxystilbene glucoside on the differentiation of neural stem cells from the mesencephalon into dopaminergic neurons.
    Neurosci Lett. 2021;742:135520.
    PubMed     Abstract available


  25. DONG MX, Hu L, Wei YD, Chen GH, et al
    Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson's disease related anxiety disorder.
    Neurosci Lett. 2021 Jan 10:135626. doi: 10.1016/j.neulet.2021.135626.
    PubMed     Abstract available


  26. TAGHIZADEH G, Joghataei MT, Goudarzi S, Bakhsheshi M, et al
    King's Parkinson's disease Pain Scale Cut-off Points for Detection of Pain Severity Levels: A Reliability and Validity Study.
    Neurosci Lett. 2021 Jan 8:135620. doi: 10.1016/j.neulet.2020.135620.
    PubMed     Abstract available


    December 2020
  27. YU LH, Peng GP, Yuan Y, Liu XY, et al
    Novel compound heterozygous of PARKIN causes early-onset Parkinson's disease.
    Neurosci Lett. 2020;744:135597.
    PubMed     Abstract available


    November 2020
  28. FLORES-SOTO ME, Corona-Angeles JA, Tejeda-Martinez AR, Flores-Guzman PA, et al
    beta-CARYOPHYLLENE EXERTS PROTECTIVE ANTIOXIDANT EFFECTS THROUGH THE ACTIVATION OF NQO1 IN THE MPTP MODEL OF PARKINSON'S DISEASE.
    Neurosci Lett. 2020 Nov 30:135534. doi: 10.1016/j.neulet.2020.135534.
    PubMed     Abstract available


  29. USENKO TS, Bezrukova AI, Bogdanova DA, Kopytova AE, et al
    Genetics variants and expression of the SCARB2 gene in the pathogenesis of Parkinson's disease in Russia.
    Neurosci Lett. 2020 Nov 20:135509. doi: 10.1016/j.neulet.2020.135509.
    PubMed     Abstract available


  30. WANG S, Zhang Y, Lei J, Guo S, et al
    Investigation of Sensorimotor Dysfunction in Parkinson Disease by Resting-state fMRI.
    Neurosci Lett. 2020 Nov 19:135512. doi: 10.1016/j.neulet.2020.135512.
    PubMed     Abstract available


  31. LI MG, Bian XB, Zhang J, Wang ZF, et al
    Aberrant Voxel-based Degree Centrality in Parkinson's Disease Patients with Mild Cognitive Impairment.
    Neurosci Lett. 2020 Nov 17:135507. doi: 10.1016/j.neulet.2020.135507.
    PubMed     Abstract available


  32. QI H, Shen D, Jiang C, Wang H, et al
    Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP/MPP(+)-induced Parkinson's disease.
    Neurosci Lett. 2020 Nov 9:135493. doi: 10.1016/j.neulet.2020.135493.
    PubMed     Abstract available


  33. LIU Z, Ye Q, Wang F, Guo Y, et al
    Protective effect of thioredoxin reductase 1 in Parkinson's disease.
    Neurosci Lett. 2020 Nov 7:135457. doi: 10.1016/j.neulet.2020.135457.
    PubMed     Abstract available


  34. BALTUS THL, Morelli NR, de Farias CC, Trugilo KP, et al
    Association of -94 ATTG insertion/deletion NFkB1 and c.*126G>A NFkBIA genetic polymorphisms with oxidative and nitrosative stress biomarkers in Brazilian subjects with Parkinson's Disease.
    Neurosci Lett. 2020;740:135487.
    PubMed     Abstract available


  35. HUANG S, Zhao Z, Ma J, Hu S, et al
    Increased plasma orexin-A concentrations are associated with the Non-motor symptoms in Parkinson's disease patients.
    Neurosci Lett. 2020 Nov 5:135480. doi: 10.1016/j.neulet.2020.135480.
    PubMed     Abstract available


  36. YANG Q, Nanivadekar S, Taylor PA, Dou Z, et al
    Executive function network's white matter alterations relate to Parkinson's disease motor phenotype.
    Neurosci Lett. 2020 Nov 5:135486. doi: 10.1016/j.neulet.2020.135486.
    PubMed     Abstract available


    October 2020
  37. SAHAI S, Effendi ET, Mahoney EC, Tucker HR, et al
    Effects of subthalamic nucleus deep brain stimulation on neuronal spiking activity in the substantia nigra pars compacta in a rat model of Parkinson's disease.
    Neurosci Lett. 2020;739:135443.
    PubMed     Abstract available


  38. SONG MK, Lee JH, Kim J, Kim JH, et al
    Neuroprotective effect of NXP031 in the MPTP-induced Parkinson's disease model.
    Neurosci Lett. 2020 Oct 16:135425. doi: 10.1016/j.neulet.2020.135425.
    PubMed     Abstract available


  39. KESH S, Kannan RR, Sivaji K, Balakrishnan A, et al
    Hesperidin downregulates kinases lrrk2 and gsk3beta in a 6-OHDA induced Parkinson's disease model.
    Neurosci Lett. 2020 Oct 16:135426. doi: 10.1016/j.neulet.2020.135426.
    PubMed     Abstract available


    September 2020
  40. SUBRAMANIAN N, Ramanathan S, Venkatesan V, Koshy T, et al
    A Case-Control Association of RANTES (-28C >G) and CCR5-Delta32 Polymorphisms with Parkinson's Disease in Indians.
    Neurosci Lett. 2020 Sep 25:135404. doi: 10.1016/j.neulet.2020.135404.
    PubMed     Abstract available


  41. CANKARA FN, Gunaydin C, Bilge SS, Ozmen O, et al
    The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta.
    Neurosci Lett. 2020;738:135308.
    PubMed     Abstract available


  42. YILMAZ NH, Calisoglu P, Guntekin B, Hanoglu L, et al
    Correlation between alpha activity and neuropsychometric tests in Parkinson's disease.
    Neurosci Lett. 2020;738:135346.
    PubMed     Abstract available


  43. SUN C, Jia G, Wang X, Wang Y, et al
    Immunoproteasome is up-regulated in rotenone-induced Parkinson's disease rat model.
    Neurosci Lett. 2020 Sep 6:135360. doi: 10.1016/j.neulet.2020.135360.
    PubMed     Abstract available


    August 2020
  44. QIU X, He H, Huang Y, Wang J, et al
    Genome-wide identification of m(6)A-associated single-nucleotide polymorphisms in Parkinson's disease.
    Neurosci Lett. 2020;737:135315.
    PubMed     Abstract available


  45. FATTAH A, Amiri F, Mohammadian M, Alipourfard I, et al
    Dysregulation of body antioxidant content is related to initiation and progression of Parkinson's disease.
    Neurosci Lett. 2020;736:135297.
    PubMed     Abstract available


    July 2020
  46. INOSE Y, Izumi Y, Yuki TT, Akaike A, et al
    Protective effects of Nrf2-ARE activator on dopaminergic neuronal loss in Parkinson disease model mice: Possible involvement of heme oxygenase-1.
    Neurosci Lett. 2020 Jul 23:135268. doi: 10.1016/j.neulet.2020.135268.
    PubMed     Abstract available


  47. JIN J, Xue L, Bai X, Zhang X, et al
    Association between epidermal growth factor receptor gene polymorphisms and susceptibility to Parkinson's disease.
    Neurosci Lett. 2020 Jul 23:135273. doi: 10.1016/j.neulet.2020.135273.
    PubMed     Abstract available


  48. JIN H, Gu HY, Mao CJ, Chen J, et al
    Association of inflammatory factors and aging in Parkinson's disease.
    Neurosci Lett. 2020 Jul 16:135259. doi: 10.1016/j.neulet.2020.135259.
    PubMed     Abstract available


  49. HUANG M, Wang Y, Wang L, Chen B, et al
    APOE rs405509 polymorphism and Parkinson's disease risk in the Chinese population.
    Neurosci Lett. 2020;736:135256.
    PubMed     Abstract available


  50. PANDI S, Chinniah R, Sevak V, Ravi PM, et al
    Association of slow acetylator genotype of N-acetyltransferase 2 with Parkinson's disease in south Indian population.
    Neurosci Lett. 2020;735:135260.
    PubMed     Abstract available


  51. GAO T, Zheng R, Ruan Y, Fang Y, et al
    Association of ZNF184, IL1R2, LRRK2, ITPKB, and PARK16 with sporadic Parkinson's disease in Eastern China.
    Neurosci Lett. 2020;735:135261.
    PubMed     Abstract available


  52. LI Z, Liu W, Xiao C, Wang X, et al
    Abnormal white matter microstructures in Parkinson's disease and comorbid depression: a whole-brain diffusion tensor imaging study.
    Neurosci Lett. 2020 Jul 6:135238. doi: 10.1016/j.neulet.2020.135238.
    PubMed     Abstract available


    June 2020
  53. MASIH A, Singh S, Agnihotri AK, Giri S, et al
    Design and development of 1,3,5-triazine-thiadiazole hybrids as potent adenosine A2A receptor (A2AR) antagonist for benefit in Parkinson's disease.
    Neurosci Lett. 2020;735:135222.
    PubMed     Abstract available


  54. ASLAN NS, Orhan G, Karahalil B
    The impacts of prominent gene polymorphisms in DNA repair enzymes on Parkinson's disease.
    Neurosci Lett. 2020;735:135203.
    PubMed     Abstract available


  55. AWOGBINDIN IO, Ishola IO, St-Pierre MK, Carrier M, et al
    Remodeling microglia to a protective phenotype in Parkinson's disease?
    Neurosci Lett. 2020 Jun 16:135164. doi: 10.1016/j.neulet.2020.135164.
    PubMed     Abstract available


    May 2020
  56. RUAN Y, Zheng R, Lin ZH, Gao T, et al
    Genetic analysis of arylsulfatase A (ARSA) in Chinese patients with Parkinson's disease.
    Neurosci Lett. 2020 May 26:135094. doi: 10.1016/j.neulet.2020.135094.
    PubMed     Abstract available


  57. JIA E, Pan M, Liu Z, Zhou Y, et al
    Transcriptomic profiling of differentially expressed genes and related pathways in different brain regions in Parkinson's disease.
    Neurosci Lett. 2020 May 21:135074. doi: 10.1016/j.neulet.2020.135074.
    PubMed     Abstract available


  58. CHEN H, Jin YH, Xue YY, Chen YL, et al
    Novel ATP13A2 and PINK1 variants identified in Chinese patients with Parkinson's disease by whole-exome sequencing.
    Neurosci Lett. 2020 May 21:135075. doi: 10.1016/j.neulet.2020.135075.
    PubMed     Abstract available


  59. LIU HJ, Li XY, Chen H, Yu HL, et al
    Identification of susceptibility loci for cognitive impairment in a cohort of Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2020 May 10:135034. doi: 10.1016/j.neulet.2020.135034.
    PubMed     Abstract available


    April 2020
  60. WANG J, Liu Y, Liu Y, Zhu K, et al
    The association between TLR3 rs3775290 polymorphism and sporadic Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2020 Apr 23:135005. doi: 10.1016/j.neulet.2020.135005.
    PubMed     Abstract available


  61. QIU X, Huang Y, Cen L, Chen X, et al
    Association of GLP-1 receptor gene polymorphisms with sporadic Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2020 Apr 22:135004. doi: 10.1016/j.neulet.2020.135004.
    PubMed     Abstract available


  62. JIN X, Li J, Li W, Wang X, et al
    Weighted gene co-expression network analysis reveals specific modules and biomarkers in Parkinson's Disease.
    Neurosci Lett. 2020 Apr 7:134950. doi: 10.1016/j.neulet.2020.134950.
    PubMed     Abstract available


  63. LENG B, Sun H, Zhao J, Liu Y, et al
    Plasma exosomal prion protein levels are correlated with cognitive decline in PD patients.
    Neurosci Lett. 2020;723:134866.
    PubMed     Abstract available


    March 2020
  64. KOSKI SK, Leino S, Panula P, Rannanpaa S, et al
    Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson's disease.
    Neurosci Lett. 2020 Mar 26:134932. doi: 10.1016/j.neulet.2020.134932.
    PubMed     Abstract available


  65. XU X, Xiong S, Zhou X, Chen X, et al
    SAP97 polymorphisms is associated with early onset Parkinson's disease.
    Neurosci Lett. 2020 Mar 26:134931. doi: 10.1016/j.neulet.2020.134931.
    PubMed     Abstract available


  66. HU X, Mao C, Hu Z, Zhang Z, et al
    Association Analysis of 15 GWAS-linked Loci with Parkinson's Disease in Chinese Han Population.
    Neurosci Lett. 2020 Mar 9:134867. doi: 10.1016/j.neulet.2020.134867.
    PubMed     Abstract available


    February 2020
  67. ZHANG X, Xue L, Sun X, Jin J, et al
    Association of IL-16 gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population.
    Neurosci Lett. 2020 Feb 28:134877. doi: 10.1016/j.neulet.2020.134877.
    PubMed     Abstract available


  68. SONG G, Xi G, Li Y, Zhao Y, et al
    Double triggers, nasal induction of a Parkinson's disease mouse model.
    Neurosci Lett. 2020;724:134869.
    PubMed     Abstract available


  69. WANG MD, Yao YN, Tang XC, Tang B, et al
    Reduced plasma progranulin levels are associated with the severity of Parkinson's disease.
    Neurosci Lett. 2020 Feb 26:134873. doi: 10.1016/j.neulet.2020.134873.
    PubMed     Abstract available


  70. FURLONG RM, O'Keeffe GW, O'Neill C, Sullivan AM, et al
    Alterations in alpha-synuclein and PINK1 expression reduce neurite length and induce mitochondrial fission and Golgi fragmentation in midbrain neurons.
    Neurosci Lett. 2020;720:134777.
    PubMed     Abstract available


  71. HANOGLU L, Saricaoglu M, Toprak G, Yilmaz NH, et al
    PRELIMINARY FINDINGS ON THE ROLE OF HIGH-FREQUENCY (5Hz) rTMS STIMULATION ON M1 AND Pre-SMA REGIONS IN PARKINSON'S DISEASE.
    Neurosci Lett. 2020 Feb 11:134837. doi: 10.1016/j.neulet.2020.134837.
    PubMed     Abstract available


    January 2020
  72. GAO J, Teng J, Liu Z, Cai M, et al
    Association between vitamin D receptor polymorphisms and susceptibility to Parkinson's disease: An updated meta-analysis.
    Neurosci Lett. 2020;720:134778.
    PubMed     Abstract available


  73. SANNA A, Follesa P, Puligheddu M, Cannas A, et al
    Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels.
    Neurosci Lett. 2020;716:134653.
    PubMed     Abstract available


    December 2019
  74. HU W, Wang L, Chen B, Wang X, et al
    Vitamin D receptor rs2228570 polymorphism and Parkinson's disease risk in a Chinese population.
    Neurosci Lett. 2019;717:134722.
    PubMed     Abstract available


  75. BI M, Kang S, Du X, Jiao Q, et al
    Association between SNCA rs356220 polymorphism and Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2019;717:134703.
    PubMed     Abstract available


  76. SONG J, Lee SS, Lim S, Yeo S, et al
    Mechanism of the neuroprotective effect of injecting brain cells on ST36 in an animal model of Parkinson's disease.
    Neurosci Lett. 2019;717:134698.
    PubMed     Abstract available


    November 2019
  77. PARKHE A, Parekh P, Nalla LV, Sharma N, et al
    Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
    Neurosci Lett. 2019 Nov 25:134652. doi: 10.1016/j.neulet.2019.134652.
    PubMed     Abstract available


  78. LI X, Yang W, Li X, Chen M, et al
    Alpha-synuclein oligomerization and dopaminergic degeneration occur synchronously in the brain and colon of MPTP-intoxicated parkinsonian monkeys.
    Neurosci Lett. 2019 Nov 20:134640. doi: 10.1016/j.neulet.2019.134640.
    PubMed     Abstract available


  79. SEKAR S, Taghibiglou C
    Nuclear accumulation of GAPDH, GluA2 and p53 in Post-mortem Substantia Nigral region of Patients with Parkinson's Disease.
    Neurosci Lett. 2019 Nov 20:134641. doi: 10.1016/j.neulet.2019.134641.
    PubMed     Abstract available


  80. KATAYAMA T, Sawada J, Kikuchi-Takeguchi S, Kano K, et al
    Cerebrospinal fluid levels of alpha-synuclein, amyloid beta, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and n
    Neurosci Lett. 2019 Nov 13:134564. doi: 10.1016/j.neulet.2019.134564.
    PubMed     Abstract available


  81. CHEN W, Yan X, Lv H, Liu Y, et al
    Gender differences in prevalence of LRRK2-associated Parkinson diseaseA meta-analysis of observational studies.
    Neurosci Lett. 2019 Nov 4:134609. doi: 10.1016/j.neulet.2019.134609.
    PubMed     Abstract available


    October 2019
  82. ZHANG Y, Chen J, Xu C, Feng J, et al
    Effects of glucocerebrosidase gene polymorphisms and mutations on the risk of Parkinson's disease dementia: a meta-analysis.
    Neurosci Lett. 2019 Oct 28:134544. doi: 10.1016/j.neulet.2019.134544.
    PubMed     Abstract available


  83. IWAOKA K, Otsuka C, Maeda T, Yamahara K, et al
    Impaired metabolism of kynurenine and its metabolites in CSF of Parkinson's disease.
    Neurosci Lett. 2019 Oct 22:134576. doi: 10.1016/j.neulet.2019.134576.
    PubMed     Abstract available


  84. FINE JM, Stroebel BM, Faltesek KA, Terai K, et al
    Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease.
    Neurosci Lett. 2019;714:134567.
    PubMed     Abstract available


    September 2019
  85. SHARMA S, Awasthi A, Singh S
    Altered Gut Microbiota and Intestinal Permeability in Parkinson's disease: Pathological highlight to Management.
    Neurosci Lett. 2019 Sep 24:134516. doi: 10.1016/j.neulet.2019.134516.
    PubMed     Abstract available


    August 2019
  86. XIE SP, Zhou F, Li J, Duan SJ, et al
    NEAT1 regulates MPP(+)-induced neuronal injury by targeting miR-124 in neuroblastoma cells.
    Neurosci Lett. 2019;708:134340.
    PubMed     Abstract available


  87. MORIYA S, Tan VP, Yee AK, Parhar IS, et al
    pink1, atp13a2 and uchl1 expressions are affected by inflammation in the brain.
    Neurosci Lett. 2019;708:134330.
    PubMed     Abstract available


  88. TEJERA-PARRADO C, Jesus S, Perinan MT, Buiza-Rueda D, et al
    A replication study of GWAS-genetic risk variants associated with Parkinson's disease in a Spanish population.
    Neurosci Lett. 2019 Aug 17:134425. doi: 10.1016/j.neulet.2019.134425.
    PubMed     Abstract available


  89. BANDOOKWALA M, Kumar Sahu A, Thakkar D, Sharma M, et al
    Edaravone-caffeine combination for the effective management of rotenone induced Parkinson's disease in rats: An evidence based affirmative from a comparative analysis of behavior and biomarker expression.
    Neurosci Lett. 2019 Aug 15:134438. doi: 10.1016/j.neulet.2019.134438.
    PubMed     Abstract available


    July 2019
  90. GUIMARAES MARQUES MJ, Real CC, Balduino Victorino D, Britto LR, et al
    Endogenous protection against the 6-OHDA model of Parkinson's disease in the Amazonian rodent Proechimys.
    Neurosci Lett. 2019 Jul 17:134381. doi: 10.1016/j.neulet.2019.134381.
    PubMed     Abstract available


  91. HOU B, Zhang X, Liu Z, Wang J, et al
    Association of rs356219 and rs3822086 polymorphisms with the risk of Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2019 Jul 17:134380. doi: 10.1016/j.neulet.2019.134380.
    PubMed     Abstract available


  92. KRISHNAMOORTHY A, Sevanan M, Mani S, Balu M, et al
    Chrysin restores MPTP induced neuroinflammation, oxidative stress and neurotrophic factors in an acute Parkinson's disease mouse model.
    Neurosci Lett. 2019 Jul 17:134382. doi: 10.1016/j.neulet.2019.134382.
    PubMed     Abstract available


  93. SHI K, Liu X, Hou L, Qiao D, et al
    Effects of exercise on mGluR-mediated glutamatergic transmission in the striatum of hemiparkinsonian rats.
    Neurosci Lett. 2019;705:143-150.
    PubMed     Abstract available


  94. HU F, Duan M, Peng N
    Knockdown of TRB3 improved the MPP(+)/MPTP-induced Parkinson's disease through the MAPK and AKT signaling pathways.
    Neurosci Lett. 2019;709:134352.
    PubMed     Abstract available


    June 2019
  95. MEDEIROS COSTA C, de Oliveira GL, Sousa Fonseca AC, de Carvalho Lana R, et al
    Levels of cortisol and neurotrophic factor brain-derived in Parkinson's disease.
    Neurosci Lett. 2019 Jun 29:134359. doi: 10.1016/j.neulet.2019.134359.
    PubMed     Abstract available


  96. RABENSTEIN M, Besong Agbo D, Wolf E, Dams J, et al
    Effect of naturally occurring alpha-synuclein-antibodies on toxic alpha-synuclein-fragments.
    Neurosci Lett. 2019;704:181-188.
    PubMed     Abstract available


  97. BUARD I, Dewispelaere WD, Teale P, Rojas DC, et al
    Auditory Entrainment of Motor Responses in Older Adults with and without Parkinson's disease: an MEG study.
    Neurosci Lett. 2019 Jun 18:134331. doi: 10.1016/j.neulet.2019.134331.
    PubMed     Abstract available


  98. LI F, Wang P, Chen Z, Sui X, et al
    Alteration of the fecal microbiota in North-eastern Han Chinese population with sporadic Parkinson's disease.
    Neurosci Lett. 2019 Jun 11:134297. doi: 10.1016/j.neulet.2019.134297.
    PubMed     Abstract available


  99. HENDERSON MX, Trojanowski JQ, Lee VM
    alpha-Synuclein Pathology in Parkinson's Disease and Related alpha-Synucleinopathies.
    Neurosci Lett. 2019 Jun 3:134316. doi: 10.1016/j.neulet.2019.134316.
    PubMed     Abstract available


  100. LIU B, Luo W, Mo Y, Wei C, et al
    Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease.
    Neurosci Lett. 2019 Jun 2:134313. doi: 10.1016/j.neulet.2019.134313.
    PubMed     Abstract available


    May 2019
  101. HEMMATI-DINARVAND M, Saedi S, Valilo M, Kalantary-Charvadeh A, et al
    Oxidative stress and Parkinson's disease: conflict of oxidant-antioxidant systems.
    Neurosci Lett. 2019 May 30:134296. doi: 10.1016/j.neulet.2019.134296.
    PubMed     Abstract available


  102. DEL FABBRO L, Rossito Goes A, Jesse CR, de Gomes MG, et al
    Chrysin protects against behavioral, cognitive and neurochemical alterations in a 6-hydroxydopamine model of Parkinson's disease.
    Neurosci Lett. 2019 May 20. pii: S0304-3940(19)30354.
    PubMed     Abstract available


  103. ZHENG J, Zang Q, Hu F, Wei H, et al
    Alpha-synuclein gene polymorphism affects risk of dementia in Han Chinese with Parkinson's disease.
    Neurosci Lett. 2019;706:146-150.
    PubMed     Abstract available


  104. HERAVI M, Dargahi L, Parsafar S, Tayaranian Marvian A, et al
    The primary neuronal cells are more resistant than PC12 cells to alpha-synuclein toxic aggregates.
    Neurosci Lett. 2019;701:38-47.
    PubMed     Abstract available


  105. BOROS FA, Torok R, Vagvolgyi-Sumegi E, Pesei Z, et al
    Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Neurosci Lett. 2019 May 11. pii: S0304-3940(19)30332.
    PubMed     Abstract available


  106. HU J, Xiao C, Gong D, Qiu C, et al
    Regional homogeneity analysis of major Parkinson's disease subtypes based on functional magnetic resonance imaging.
    Neurosci Lett. 2019 May 11. pii: S0304-3940(19)30331.
    PubMed     Abstract available


  107. FOLLETT J, Fox JD, Gustavsson EK, Kadgien C, et al
    DNAJC13 p.Asn855Ser, implicated in familial parkinsonism, alters membrane dynamics of Sorting Nexin 1.
    Neurosci Lett. 2019 May 10. pii: S0304-3940(19)30285.
    PubMed     Abstract available


  108. GHOSH A, Sadhukhan T, Giri S, Biswas A, et al
    Dopamine beta Hydroxylase (DBH) is a potential modifier gene associated with Parkinson's disease in Eastern India.
    Neurosci Lett. 2019 May 10. pii: S0304-3940(19)30333.
    PubMed     Abstract available


  109. DONG X, Zheng D, Nao J
    Measurement of serum cystatin C: A valuable tool for evaluating dyskinesia in Parkinson's disease.
    Neurosci Lett. 2019;705:172-176.
    PubMed     Abstract available


    April 2019
  110. FATIMA A, Rahul, Siddique YH
    Role of tangeritin against cognitive impairments in transgenic Drosophila model of Parkinson's disease.
    Neurosci Lett. 2019;705:112-117.
    PubMed     Abstract available


  111. ZHANG J, Jia G, Yang Z, Liu D, et al
    Impact of subthalamic nucleus stimulation did not differ on young-onset and older-onset Parkinson's disease: A three-year follow up.
    Neurosci Lett. 2019;705:99-105.
    PubMed     Abstract available


  112. ZHONG J, Guan X, Zhong X, Cao F, et al
    Levodopa imparts a normalizing effect on default-mode network connectivity in non-demented Parkinson's disease.
    Neurosci Lett. 2019 Apr 23. pii: S0304-3940(19)30284.
    PubMed     Abstract available


  113. MILLER S, Muqit MMK
    Therapeutic Approaches To Enhance PINK1/Parkin Mediated Mitophagy For The Treatment Of Parkinson's Disease.
    Neurosci Lett. 2019 Apr 14. pii: S0304-3940(19)30263.
    PubMed     Abstract available


  114. PAPAGIANNAKIS N, Xilouri M, Koros C, Simitsi AM, et al
    Autophagy dysfunction in peripheral blood mononuclear cells of Parkinson's disease patients.
    Neurosci Lett. 2019;704:112-115.
    PubMed     Abstract available


  115. MA LY, Gao LY, Li X, Ma HZ, et al
    Nitrated alpha-synuclein in minor salivary gland biopsies in Parkinson's disease.
    Neurosci Lett. 2019 Apr 1. pii: S0304-3940(19)30226.
    PubMed     Abstract available


    March 2019
  116. SUSAN B, James R, Bonnie R, Joseph H, et al
    Neuroprotective effects of acetyl-L-carnitine (ALC) in a chronic MPTP-induced Parkinson's disease mouse model: Endothelial and microglial effects.
    Neurosci Lett. 2019 Mar 16. pii: S0304-3940(19)30170.
    PubMed     Abstract available


  117. WANG L, Li NN, Lu ZJ, Li JY, et al
    Association of three candidate genetic variants in ACMSD/TMEM163, GPNMB and BCKDK /STX1B with sporadic Parkinson's disease in Han Chinese.
    Neurosci Lett. 2019 Mar 14. pii: S0304-3940(19)30173.
    PubMed     Abstract available


    February 2019
  118. WANG Z, Sun L, Jia K, Wang H, et al
    miR-9-5p modulates the progression of Parkinson's disease by targeting SIRT1.
    Neurosci Lett. 2019 Feb 28. pii: S0304-3940(19)30130.
    PubMed     Abstract available


  119. GUDUCU C, Eskicioglu E, Oz D, Oniz A, et al
    Auditory Brain Oscillatory Responses in Drug-naive Patients with Parkinson's Disease.
    Neurosci Lett. 2019 Feb 28. pii: S0304-3940(19)30131.
    PubMed     Abstract available


  120. WANG X, Shen N, Lu Y, Tan K, et al
    Vitamin D receptor polymorphisms and the susceptibility of Parkinson's disease.
    Neurosci Lett. 2019 Feb 11. pii: S0304-3940(19)30101.
    PubMed     Abstract available


  121. GUNAYDIN C, Avci B, Bozkurt A, Onger ME, et al
    Effects of Agomelatine in Rotenone-induced Parkinson's Disease in Rats.
    Neurosci Lett. 2019 Feb 1. pii: S0304-3940(19)30075.
    PubMed     Abstract available


    January 2019
  122. KAWAMURA M, Sato S, Matsumoto G, Fukuda T, et al
    Loss of nuclear REST/NRSF in aged-dopaminergic neurons in Parkinson's disease patients.
    Neurosci Lett. 2019 Jan 23. pii: S0304-3940(19)30054.
    PubMed     Abstract available


    December 2018
  123. CAO Z, Wu Y, Liu G, Jiang Y, et al
    alpha-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Neurosci Lett. 2018;696:114-120.
    PubMed     Abstract available


  124. WANG S, Li N, Zou H, Wu M, et al
    Gut microbiome-based secondary metabolite biosynthetic gene clusters detection in Parkinson's disease.
    Neurosci Lett. 2018 Dec 17. pii: S0304-3940(18)30866.
    PubMed     Abstract available


  125. BUENO MEB, do Nascimento Neto LI, Terra MB, Barboza NM, et al
    Effectiveness of acute transcranial direct current stimulation on non-motor and motor symptoms in Parkinson's disease.
    Neurosci Lett. 2018;696:46-51.
    PubMed     Abstract available


  126. ALIZADEH R, Kamrava SK, Bagher Z, Farhadi M, et al
    Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease.
    Neurosci Lett. 2018;696:52-59.
    PubMed     Abstract available


    November 2018
  127. ZAMPIER VC, Vitorio R, Beretta VS, Jaimes DAR, et al
    Gait bradykinesia and hypometria decrease as arm swing frequency and amplitude increase.
    Neurosci Lett. 2018;687:248-252.
    PubMed     Abstract available


  128. WANG Z, Kuang P, Lin Y, Liu W, et al
    Re-expression of voltage-gated sodium channel subtype Nav1.3 in the substantia nigra after dopamine depletion.
    Neurosci Lett. 2018;687:146-152.
    PubMed     Abstract available


  129. LEVY-GIGI E, Haim-Nahum S, Hall JM, Crouse J, et al
    The interactive effect of valence and context on reversal learning in individuals with Parkinson's disease.
    Neurosci Lett. 2018 Nov 6. pii: S0304-3940(18)30751.
    PubMed     Abstract available


    October 2018
  130. MIRANDA-MORALES EG, Sandoval-Carrillo A, Castellanos-Juarez FX, Mendez-Hernandez EM, et al
    H1/H2 MAPT haplotype and Parkinson's Disease in Mexican mestizo population.
    Neurosci Lett. 2018 Oct 16. pii: S0304-3940(18)30705.
    PubMed     Abstract available


  131. PURCARO C, Vanacore N, Moret F, Di Battista ME, et al
    DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease.
    Neurosci Lett. 2018 Oct 11. pii: S0304-3940(18)30697.
    PubMed     Abstract available


  132. SHISHIDO T, Nagano Y, Araki M, Kurashige T, et al
    Synphilin-1 has neuroprotective effects on MPP(+)-induced Parkinson's disease model cells by inhibiting ROS production and apoptosis.
    Neurosci Lett. 2018 Oct 11. pii: S0304-3940(18)30696.
    PubMed     Abstract available


  133. FONSECA-FONSECA LA, Wong-Guerra M, Ramirez-Sanchez J, Montano-Peguero Y, et al
    JM-20, a novel hybrid molecule, protects against rotenone-induced neurotoxicity in experimental model of Parkinson's disease.
    Neurosci Lett. 2018 Oct 7. pii: S0304-3940(18)30678.
    PubMed     Abstract available


    September 2018
  134. JIN L, Wan W, Wang L, Wang C, et al
    Elevated microRNA-520d-5p in the serum of patients with Parkinson's disease, possibly through regulation of cereloplasmin expression.
    Neurosci Lett. 2018 Sep 19. pii: S0304-3940(18)30640.
    PubMed     Abstract available


  135. LU J, Chen S, Shen M, He Q, et al
    Mitochondrial regulation by pyrroloquinoline quinone prevents rotenone-induced neurotoxicity in Parkinson's disease models.
    Neurosci Lett. 2018 Sep 18. pii: S0304-3940(18)30637.
    PubMed     Abstract available


  136. CACABELOS R
    Pharmacogenomics of Alzheimer's and Parkinson's diseases.
    Neurosci Lett. 2018 Sep 17. pii: S0304-3940(18)30624.
    PubMed     Abstract available


  137. CRUZ CF, Piemonte MEP, Okai-Nobrega LA, Okamoto E, et al
    Parkinson's disease does not alter automatic visual-motor coupling in postural control.
    Neurosci Lett. 2018;686:47-52.
    PubMed     Abstract available


    August 2018
  138. CHOI DJ, Kwon JK, Joe EH
    A Parkinson's disease gene, DJ-1, regulates astrogliosis through STAT3.
    Neurosci Lett. 2018;685:144-149.
    PubMed     Abstract available


  139. CHEN Y, Cao B, Chen X, Ou R, et al
    The relationship between four GWAS-identified loci in Alzheimer's disease and the risk of Parkinson's disease, amyotrophic lateral sclerosis, and multiple system atrophy.
    Neurosci Lett. 2018 Aug 22. pii: S0304-3940(18)30569.
    PubMed     Abstract available


    July 2018
  140. LI D, Song X, Huang H, Huang H, et al
    Association of Parkinson's disease-related pain with plasma interleukin-1, interleukin-6, interleukin-10, and tumour necrosis factor-alpha.
    Neurosci Lett. 2018 Jul 28. pii: S0304-3940(18)30500.
    PubMed     Abstract available


  141. GE F, Ding J, Liu Y, Lin H, et al
    Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: a meta-analysis.
    Neurosci Lett. 2018 Jul 20. pii: S0304-3940(18)30503.
    PubMed     Abstract available


  142. ROSAS-HERNANDEZ H, Chigurupati S, Raymick J, Robinson B, et al
    Identification of altered microRNAs in serum of a mouse model of Parkinson's disease.
    Neurosci Lett. 2018;687:1-9.
    PubMed     Abstract available


  143. SI QQ, Yuan YS, Zhi Y, Tong Q, et al
    Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson's disease.
    Neurosci Lett. 2018;684:42-46.
    PubMed     Abstract available


    June 2018
  144. MARTIN-RODRIGUEZ JF, Mir P
    Short-afferent inhibition and cognitive impairment in Parkinson's disease: A Quantitative Review and Challenges.
    Neurosci Lett. 2018 Jun 27. pii: S0304-3940(18)30451.
    PubMed     Abstract available


  145. SHEN YT, Li JY, Yuan YS, Wang XX, et al
    Disrupted amplitude of low-frequency fluctuations and causal connectivity in Parkinson's disease with apathy.
    Neurosci Lett. 2018;683:75-81.
    PubMed     Abstract available


  146. LUCA A, Nicoletti A, Mostile G, Sciacca G, et al
    Temperament Traits And Executive Functions In Parkinson's Disease.
    Neurosci Lett. 2018 Jun 22. pii: S0304-3940(18)30443.
    PubMed     Abstract available


  147. LUOMA J, Pekkonen E, Airaksinen K, Helle L, et al
    Spontaneous sensorimotor cortical activity is suppressed by deep brain stimulation in patients with advanced Parkinson's disease.
    Neurosci Lett. 2018 Jun 22. pii: S0304-3940(18)30444.
    PubMed     Abstract available


  148. KWIATEK-MAJKUSIAK J, Geremek M, Koziorowski D, Tomasiuk R, et al
    Higher serum levels of pro-hepcidin in patients with Parkinson's disease treated with deep brain stimulation.
    Neurosci Lett. 2018 Jun 18. pii: S0304-3940(18)30434.
    PubMed     Abstract available


  149. DU G, Zhuang P, Zhang Y, Li J, et al
    Neuronal firing rate and oscillatory patterns in the basal ganglia nuclei differ from those of the ventrolateral thalamus in patients with Parkinson disease.
    Neurosci Lett. 2018;683:1-6.
    PubMed     Abstract available


  150. PING Z, Xiaomu W, Xufang X, Wenfeng C, et al
    GAPDH rs1136666 SNP indicates a high risk of Parkinson's disease.
    Neurosci Lett. 2018 Jun 7. pii: S0304-3940(18)30416.
    PubMed     Abstract available


  151. NAGARAJAN VB, Marathe PA
    Effect of montelukast in experimental model of Parkinson's disease.
    Neurosci Lett. 2018 Jun 6. pii: S0304-3940(18)30403.
    PubMed     Abstract available


    May 2018
  152. SHU L, Zhang Y, Sun Q, Pan H, et al
    SNCA REP1 and Parkinson's disease.
    Neurosci Lett. 2018 May 30. pii: S0304-3940(18)30394.
    PubMed     Abstract available


  153. KUMARI N, Agrawal S, Kumari R, Sharma D, et al
    Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease.
    Neurosci Lett. 2018;675:74-82.
    PubMed     Abstract available


  154. ZHANG S, Chen S, Liu A, Wan J, et al
    Inhibition of BDNF production by MPP(+) through up-regulation of miR-210-3p contributes to dopaminergic neuron damage in MPTP model.
    Neurosci Lett. 2018;675:133-139.
    PubMed     Abstract available


  155. POWELL DW, Blackmore SE, Puppa M, Lester D, et al
    Deep brain stimulation enhances movement complexity during gait in individuals with Parkinson's disease.
    Neurosci Lett. 2018 May 8. pii: S0304-3940(18)30337.
    PubMed     Abstract available


  156. BEGUM M ET, Sen D
    DOR agonist (SNC-80) exhibits anti-parkinsonian effect via downregulating UPR/oxidative stress signals and inflammatory response in vivo.
    Neurosci Lett. 2018;678:29-36.
    PubMed     Abstract available


    April 2018
  157. FANG L, Tang BS, Fan K, Wan CM, et al
    Alzheimer's disease susceptibility genes modify the risk of Parkinson disease and Parkinson's disease-associated cognitive impairment.
    Neurosci Lett. 2018 Apr 23. pii: S0304-3940(18)30305.
    PubMed     Abstract available


  158. PUPYSHEV AB, Korolenko TA, Akopyan AA, Amstislavskaya TG, et al
    Suppression of autophagy in the brain of transgenic mice with overexpression of capital A, Cyrillic53capital TE, Cyrillic-mutant alpha-synuclein as an early event at synucleinopathy progression.
    Neurosci Lett. 2018;672:140-144.
    PubMed     Abstract available


  159. WANG P, Guo Y, Song C, Liu Y, et al
    PINK1 p.K520RfsX3 Mutation Identified in a Chinese Family with Early-onset Parkinson's disease.
    Neurosci Lett. 2018 Apr 12. pii: S0304-3940(18)30283.
    PubMed     Abstract available


  160. SHEEHAN P, Yue Z
    Deregulation of autophagy and vesicle trafficking in Parkinson's disease.
    Neurosci Lett. 2018 Apr 5. pii: S0304-3940(18)30268.
    PubMed     Abstract available


  161. CHU CT
    Multiple pathways for mitophagy: A neurodegenerative conundrum for Parkinson's disease.
    Neurosci Lett. 2018 Apr 4. pii: S0304-3940(18)30259.
    PubMed     Abstract available


    March 2018
  162. CROOKS SA, Bech S, Halling J, Christiansen DH, et al
    Carnitine levels and mutations in the SLC22A5 gene in Faroes patients with Parkinson's disease.
    Neurosci Lett. 2018;675:116-119.
    PubMed     Abstract available


  163. LI W, Jiang Y, Wang Y, Yang S, et al
    MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway.
    Neurosci Lett. 2018;675:83-88.
    PubMed     Abstract available


  164. SADHUKHAN D, Das G, Biswas A, Ghosh S, et al
    Evaluation of FGF 20 variants for susceptibility to Parkinson's disease in Eastern Indians.
    Neurosci Lett. 2018 Mar 28. pii: S0304-3940(18)30236.
    PubMed     Abstract available


  165. GENG L, Zhang T, Liu W, Chen Y, et al
    miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
    Neurosci Lett. 2018;675:23-30.
    PubMed     Abstract available


  166. HOU Y, Luo C, Yang J, Ou R, et al
    Altered intrinsic brain functional connectivity in drug-naive Parkinson's disease patients with LRRK2 mutations.
    Neurosci Lett. 2018 Mar 19. pii: S0304-3940(18)30215.
    PubMed     Abstract available


  167. MAPLE-GRODEM J, Chung J, Lunde KA, Tzoulis C, et al
    Alzheimer disease associated variants in SORL1 accelerate dementia development in Parkinson disease.
    Neurosci Lett. 2018;674:123-126.
    PubMed     Abstract available


  168. WATANABE T, Saito K, Ishida K, Tanabe S, et al
    Effect of auditory stimulus on executive function and execution time during cognitively demanding stepping task in patients with Parkinson's disease.
    Neurosci Lett. 2018 Mar 17. pii: S0304-3940(18)30209.
    PubMed     Abstract available


  169. POCHMANN D, Peccin PK, da Silva IRV, Dorneles GP, et al
    Cytokine modulation in response to acute and chronic aquatic therapy intervention in Parkinson disease individuals: A pilot study.
    Neurosci Lett. 2018 Mar 11. pii: S0304-3940(18)30190.
    PubMed     Abstract available


  170. JIN H, Chen J, Li K, Zhang JR, et al
    A novel p.L216I mutation in the glucocerebrosidase gene is associated with Parkinson's disease in Han Chinese patients.
    Neurosci Lett. 2018 Mar 9. pii: S0304-3940(18)30186.
    PubMed     Abstract available


    February 2018
  171. GUO T, Guan X, Zeng Q, Xuan M, et al
    Correlations between CSF proteins and spontaneous neuronal activity in Parkinson's disease.
    Neurosci Lett. 2018;673:61-66.
    PubMed     Abstract available


  172. DUTTA P, Dargahi L, O'Connell KE, Bolia A, et al
    A novel modelling mechanism of PAEL receptor and GABARAPL2 interaction involved in Parkinson's disease.
    Neurosci Lett. 2018;673:12-18.
    PubMed     Abstract available


  173. DI NATALE C, Monaco A, Pedone C, Tessitore A, et al
    THE LEVEL OF 24-HYDROXYCHOLESTERYL ESTERS DECREASES IN PLASMA OF PATIENTS WITH PARKINSON'S DISEASE.
    Neurosci Lett. 2018 Feb 24. pii: S0304-3940(18)30123.
    PubMed     Abstract available


  174. JIANG X, Wang X, Tuo M, Ma J, et al
    RAGE and its emerging role in the pathogenesis of Parkinson's disease.
    Neurosci Lett. 2018 Feb 22. pii: S0304-3940(18)30131.
    PubMed     Abstract available


  175. ZHENG X, Chen X, Guo M, Ali S, et al
    Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model.
    Neurosci Lett. 2018 Feb 15. pii: S0304-3940(18)30100.
    PubMed     Abstract available


  176. GOMEZ G, Saborido MD, Bernardi MA, Gershanik OS, et al
    Regulation of Pleiotrophin and Fyn in the striatum of rats undergoing L-DOPA-induced dyskinesia.
    Neurosci Lett. 2018;666:5-10.
    PubMed     Abstract available


  177. SILVEIRA CRA, Roy EA, Almeida QJ
    Acute effects of aerobic exercise on cognitive function in individuals with Parkinson's disease.
    Neurosci Lett. 2018 Feb 3. pii: S0304-3940(18)30068.
    PubMed     Abstract available


    January 2018
  178. MAO W, Zhao C, Ding H, Liang K, et al
    Pyrosequencing analysis of methylation levels of clock genes in leukocytes from Parkinson's disease patients.
    Neurosci Lett. 2018;668:115-119.
    PubMed     Abstract available


  179. WANG X, Li J, Wang M, Yuan Y, et al
    Alterations of the amplitude of low-frequency fluctuations in anxiety in Parkinson's disease.
    Neurosci Lett. 2018;668:19-23.
    PubMed     Abstract available


  180. MOON HC, Won SY, Kim EG, Kim HK, et al
    Effect of optogenetic modulation on entopeduncular input affects thalamic discharge and behavior in an AAV2-alpha-synuclein-induced hemiparkinson rat model.
    Neurosci Lett. 2018;662:129-135.
    PubMed     Abstract available


  181. ZHENG Q, Huang C, Guo J, Tan J, et al
    Hsp70 participates in PINK1-mediated mitophagy by regulating the stability of PINK1.
    Neurosci Lett. 2018;662:264-270.
    PubMed     Abstract available


    December 2017
  182. SEKAR S, Taghibiglou C
    Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson's disease.
    Neurosci Lett. 2017;666:139-143.
    PubMed     Abstract available


  183. WANG L, Nie K, Zhao X, Feng S, et al
    Characteristics of gray matter morphological change in Parkinson's disease patients with semantic abstract reasoning deficits.
    Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31020.
    PubMed     Abstract available


  184. CHENG Y, Mao CY, Liu YT, Li F, et al
    Analysis of variant rs3794087 in SLC1A2 and Parkinson's disease in a Chinese Han population: a case-control study and meta-analysis.
    Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31018.
    PubMed     Abstract available


  185. HARRISON IF, Smith AD, Dexter DT
    Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.
    Neurosci Lett. 2017;666:48-57.
    PubMed     Abstract available


  186. AN C, Pu X, Xiao W, Zhang H, et al
    Expression of the DJ-1 protein in the serum of Chinese patients with Parkinson's disease.
    Neurosci Lett. 2017;665:236-239.
    PubMed     Abstract available


  187. BREZA M, Koutsis G, Karadima G, Potagas C, et al
    The different faces of the p. A53T alpha-synuclein mutation: a screening of Greek patients with parkinsonism and/or dementia.
    Neurosci Lett. 2017 Dec 9. pii: S0304-3940(17)30988.
    PubMed     Abstract available


    November 2017
  188. LI XR, Ren YD, Cao B, Huang XL, et al
    Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease.
    Neurosci Lett. 2017 Nov 30. pii: S0304-3940(17)30973.
    PubMed     Abstract available


  189. DU K, Liu MY, Pan YZ, Zhong X, et al
    Association of circulating manganese levels with Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2017;665:92-98.
    PubMed     Abstract available


  190. CAI M, Liu Z, Li W, Wang Y, et al
    Association between rs823128 polymorphism and the risk of Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2017 Nov 27. pii: S0304-3940(17)30966.
    PubMed     Abstract available


  191. PAPAGIANNAKIS N, Koros C, Stamelou M, Simitsi AM, et al
    Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson's Disease.
    Neurosci Lett. 2017 Nov 9. pii: S0304-3940(17)30910.
    PubMed     Abstract available


  192. YUAN XQ, Cao B, Wu Y, Chen YP, et al
    Association analysis of SNP rs11868035 in SREBF1 with sporadic Parkinson's disease, sporadic amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population.
    Neurosci Lett. 2017 Nov 8. pii: S0304-3940(17)30913.
    PubMed     Abstract available


    October 2017
  193. LIU L, Zhang L, Guo L, Yu Q, et al
    MTHFR C677T and A1298C polymorphisms may contribute to the risk of Parkinson's disease: A meta-analysis of 19 studies.
    Neurosci Lett. 2017;662:339-345.
    PubMed     Abstract available


  194. WU Q, Gao Y, Liu AS, Xie LZ, et al
    Large-scale cortical volume correlation networks reveal disrupted small world patterns in Parkinson's disease.
    Neurosci Lett. 2017 Oct 20. pii: S0304-3940(17)30858.
    PubMed     Abstract available


  195. MATSUURA K, Kajikawa H, Tabei KI, Satoh M, et al
    The effectiveness of istradefylline for the treatment of gait deficits and sleepiness in patients with Parkinson's disease.
    Neurosci Lett. 2017 Oct 12. pii: S0304-3940(17)30836.
    PubMed     Abstract available


    September 2017
  196. KONG P, Lei P, Zhang S, Li D, et al
    Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.
    Neurosci Lett. 2017 Sep 28. pii: S0304-3940(17)30793.
    PubMed     Abstract available


  197. GMITTEROVA K, Gawinecka J, Heinemann U, Valkovic P, et al
    DNA versus RNA oxidation in Parkinson's disease: which is more important?
    Neurosci Lett. 2017 Sep 26. pii: S0304-3940(17)30790.
    PubMed     Abstract available


  198. ABBAOUI A, Chatoui H, Hiba OE, Gamrani H, et al
    Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson's disease.
    Neurosci Lett. 2017 Sep 14. pii: S0304-3940(17)30774.
    PubMed     Abstract available


  199. XI J, Yang X, Zhao Q, Zheng J, et al
    Absence of association of the Ala58Val (rs17571) CTSD gene variant with Parkinson's disease or amyotrophic lateral sclerosis in a Han Chinese population.
    Neurosci Lett. 2017 Sep 13. pii: S0304-3940(17)30771.
    PubMed     Abstract available


  200. FLACH A, Jaegers L, Krieger M, Bixler E, et al
    Endurance Exercise Improves Function in Individuals with Parkinson's Disease: A Meta-analysis.
    Neurosci Lett. 2017 Sep 1. pii: S0304-3940(17)30733.
    PubMed     Abstract available


    August 2017
  201. CAO H, Shi J, Cao B, Kang B, et al
    Evaluation of the Braak staging of brain pathology with 1H-MRS in patients with Parkinson's disease.
    Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30697.
    PubMed     Abstract available


  202. LINDENAU JD, Altmann V, Schumacher-Schuh AF, Rieder CR, et al
    Tumor necrosis factor alpha polymorphisms are associated with Parkinson's disease age at onset.
    Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30696.
    PubMed     Abstract available


  203. FANG J, Hou B, Liu H, Zhang X, et al
    Association between SNCA rs2736990 polymorphism and Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2017;658:102-107.
    PubMed     Abstract available


  204. LUDTMANN MHR, Abramov AY
    Mitochondrial calcium imbalance in Parkinson's disease.
    Neurosci Lett. 2017 Aug 21. pii: S0304-3940(17)30691.
    PubMed     Abstract available


  205. BERGE-SEIDL V, Pihlstrom L, Maple-Grodem J, Forsgren L, et al
    The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
    Neurosci Lett. 2017 Aug 19. pii: S0304-3940(17)30687.
    PubMed     Abstract available


  206. GAO Y, Nie K, Huang B, Mei M, et al
    Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Neurosci Lett. 2017 Aug 17. pii: S0304-3940(17)30675.
    PubMed     Abstract available


  207. LV W, Guan Q, Hu X, Chen J, et al
    Vestibulo-ocular reflex abnormality in Parkinson's disease detected by video head impulse test.
    Neurosci Lett. 2017 Aug 11. pii: S0304-3940(17)30668.
    PubMed     Abstract available


  208. HE T, Wang J, Wang X, Deng W, et al
    Association between PARK16 and Parkinson's disease: a meta-analysis.
    Neurosci Lett. 2017 Aug 11. pii: S0304-3940(17)30669.
    PubMed     Abstract available


  209. XIAO H, Li M, Cai J, Li N, et al
    Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats.
    Neurosci Lett. 2017 Aug 10. pii: S0304-3940(17)30663.
    PubMed     Abstract available


  210. FANG J, Chen H, Cao Z, Jiang Y, et al
    Impaired Brain Network Architecture in Newly Diagnosed Parkinson's Disease Based on Graph Theoretical Analysis.
    Neurosci Lett. 2017 Aug 5. pii: S0304-3940(17)30638.
    PubMed     Abstract available


    July 2017
  211. RINGMAN JM, Casado M, Van Berlo V, Pa J, et al
    A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and Parkinsonism.
    Neurosci Lett. 2017 Jul 29. pii: S0304-3940(17)30618.
    PubMed     Abstract available


  212. WEILAN Y, Weiguo Y, Baisheng H, Lixiang W, et al
    Neuroprotective Effects of Lentivirus-mediated Cystathionine-beta-synthase Overexpression against 6-OHDA-induced Parkinson's Disease Rats.
    Neurosci Lett. 2017 Jul 29. pii: S0304-3940(17)30581.
    PubMed     Abstract available


  213. LI X, Xue L, Sun J, Sun Y, et al
    Single nucleotide polymorphisms in the toll-like receptor 2 (TLR2) gene are associated with sporadic Parkinson's disease in the North-eastern Han Chinese population.
    Neurosci Lett. 2017;656:72-76.
    PubMed     Abstract available


  214. REED-JONES RJ, Powell DW
    The effects of gaze stabilization on gait parameters in individuals with Parkinson's disease.
    Neurosci Lett. 2017 Jul 11. pii: S0304-3940(17)30573.
    PubMed     Abstract available


  215. YAO Z, Shao Y, Han X
    Freezing of gait is associated with cognitive impairment in patients with Parkinson disease.
    Neurosci Lett. 2017 Jul 8. pii: S0304-3940(17)30555.
    PubMed     Abstract available


    June 2017
  216. DIBILIO V, Nicoletti A, Mostile G, Portaro G, et al
    Computer-Assisted Cognitive Rehabilitation on Freezing of Gait in Parkinson's Disease: A Pilot Study.
    Neurosci Lett. 2017 Jun 9. pii: S0304-3940(17)30486.
    PubMed     Abstract available


  217. HE D, Hu P, Deng X, Song Z, et al
    Genetic analysis of the RIC3 gene in Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2017 Jun 9. pii: S0304-3940(17)30487.
    PubMed     Abstract available


  218. WANG X, Zhang J, Yuan Y, Li T, et al
    Cerebral metabolic change in Parkinson's disease patients with anxiety: A FDG-PET study.
    Neurosci Lett. 2017;653:202-207.
    PubMed     Abstract available


  219. SHIN JH, Shin SA, Lee JY, Nam H, et al
    Precuneus degeneration and isolated apathy in patients with Parkinson's disease.
    Neurosci Lett. 2017;653:250-257.
    PubMed     Abstract available


    May 2017
  220. HAO Y, Shabanpoor A, Metz GA
    Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson's disease.
    Neurosci Lett. 2017;651:79-87.
    PubMed     Abstract available


    April 2017
  221. PENG B, Wang S, Zhou Z, Liu Y, et al
    A multilevel-ROI-features-based machine learning method for detection of morphometric biomarkers in Parkinson's disease.
    Neurosci Lett. 2017 Apr 20. pii: S0304-3940(17)30335.
    PubMed     Abstract available


  222. LIU H, Liu H, Li T, Cui J, et al
    NR4A2 genetic variation and Parkinson's disease: evidence from a systematic review and meta-analysis.
    Neurosci Lett. 2017 Apr 3. pii: S0304-3940(17)30090.
    PubMed     Abstract available


  223. YANG X, Zheng J, An R, Tian S, et al
    Polymorphism in MIR4697 but not VPS13C, GCH1, or SIPA1L2 is associated with risk of Parkinson's disease in a Han Chinese population.
    Neurosci Lett. 2017 Apr 2. pii: S0304-3940(17)30287.
    PubMed     Abstract available


    March 2017
  224. CHEN S, Liu Y, Niu Y, Xu Y, et al
    Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson's disease patients.
    Neurosci Lett. 2017 Mar 27. pii: S0304-3940(17)30275.
    PubMed     Abstract available


  225. KUMARI N, Agrawal S, Luthra PM
    Pharmacological assessments of potent A2A receptor antagonist IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo[4,5-d]pyrimidin-6(7H)-yl)urea) in rodent model of haloperidol induced Parkinson like symptoms.
    Neurosci Lett. 2017;647:53-60.
    PubMed     Abstract available


  226. DEMETER G, Valalik I, Pajkossy P, Szollosi A, et al
    The effect of deep brain stimulation of the subthalamic nucleus on executive functions: Impaired verbal fluency and intact updating, planning and conflict resolution in Parkinson's disease.
    Neurosci Lett. 2017 Mar 18. pii: S0304-3940(17)30247.
    PubMed     Abstract available


  227. WANG L, Huang J, Pang S, Qin X, et al
    Genetic analysis of the ATG16L1 gene promoter in sporadic Parkinson's disease.
    Neurosci Lett. 2017;646:30-35.
    PubMed     Abstract available


    February 2017
  228. TANG Y, Meng L, Wan CM, Liu ZH, et al
    Identifying the presence of Parkinson's disease using low-frequency fluctuations in BOLD signals.
    Neurosci Lett. 2017 Feb 26. pii: S0304-3940(17)30172.
    PubMed     Abstract available


  229. CAO XY, Lu JM, Zhao ZQ, Li MC, et al
    MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.
    Neurosci Lett. 2017 Feb 18. pii: S0304-3940(17)30161.
    PubMed     Abstract available


  230. TANAKA K, Miyake Y, Fukushima W, Kiyohara C, et al
    Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson's disease in Japan.
    Neurosci Lett. 2017;643:97-102.
    PubMed     Abstract available


  231. FATHALLA AM, Soliman AM, Moustafa AA
    Selective A2A receptors blockade reduces degeneration of substantia nigra dopamine neurons in a rotenone-induced rat model of Parkinson's disease: A histological study.
    Neurosci Lett. 2017;643:89-96.
    PubMed     Abstract available


  232. MIKI Y, Tanji K, Mori F, Kakita A, et al
    PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
    Neurosci Lett. 2017 Feb 14. pii: S0304-3940(17)30133.
    PubMed     Abstract available


  233. LI Y, Huang J, Pang S, Wang H, et al
    Novel and functional ATG12 gene variants in sporadic Parkinson's disease.
    Neurosci Lett. 2017 Feb 13. pii: S0304-3940(17)30134.
    PubMed     Abstract available


  234. TIAN S, Yang X, Zhao Q, Zheng J, et al
    Association between a heme oxygenase-2 genetic variant and risk of Parkinson's disease in Han Chinese.
    Neurosci Lett. 2017 Feb 5. pii: S0304-3940(17)30114.
    PubMed     Abstract available


    January 2017
  235. KANG SY, Lee SB, Kim HJ, Kim HT, et al
    Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease.
    Neurosci Lett. 2017 Jan 27. pii: S0304-3940(17)30091.
    PubMed     Abstract available


  236. CORBILLE AG, Preterre C, Rolli-Derkinderen M, Coron E, et al
    Biochemical analysis of alpha-synuclein extracted from control and Parkinson's disease colonic biopsies.
    Neurosci Lett. 2017 Jan 23. pii: S0304-3940(17)30070.
    PubMed     Abstract available


  237. ZHANG Y, Wu JY, Weng LH, Li XX, et al
    Valproic acid protects against MPP(+)-mediated neurotoxicity in SH-SY5Y Cells through autophagy.
    Neurosci Lett. 2017;638:60-68.
    PubMed     Abstract available


  238. BRIFFA M, Ghio S, Neuner J, Gauci AJ, et al
    Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.
    Neurosci Lett. 2017;638:12-20.
    PubMed     Abstract available


    December 2016
  239. PEZZI JC, Bem CM, Rocha TJ, Schumacher-Schuh AF, et al
    Association between DNA methyltransferase gene polymorphism and Parkinson's disease.
    Neurosci Lett. 2016 Dec 29. pii: S0304-3940(16)31006.
    PubMed     Abstract available


  240. RIAL D, Morato X, Real JI, Goncalves FQ, et al
    Parkinson's disease-associated GPR37 receptor regulates cocaine-mediated synaptic depression in corticostriatal synapses.
    Neurosci Lett. 2016;638:162-166.
    PubMed     Abstract available


  241. XIANG Y, Gong T, Wu J, Li J, et al
    Subtypes evaluation of motor dysfunction in Parkinson's disease using neuromelanin-sensitive magnetic resonance imaging.
    Neurosci Lett. 2016;638:145-150.
    PubMed     Abstract available


    November 2016
  242. XIE Y, Feng H, Peng S, Xiao J, et al
    Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
    Neurosci Lett. 2016 Nov 10. pii: S0304-3940(16)30846.
    PubMed     Abstract available


  243. LATTARI E, Costa SS, Campos C, de Oliveira AJ, et al
    Can transcranial direct current stimulation on the dorsolateral prefrontal cortex improves balance and functional mobility in Parkinson's disease?
    Neurosci Lett. 2016 Nov 9. pii: S0304-3940(16)30861.
    PubMed     Abstract available


  244. CAO CY, Zeng K, Li DY, Zhan SK, et al
    Modulations on cortical oscillations by Subthalamic deep brain stimulation in patients with Parkinson disease: a MEG study.
    Neurosci Lett. 2016 Nov 3. pii: S0304-3940(16)30848.
    PubMed     Abstract available


    October 2016
  245. PCHELINA S, Emelyanov A, Baydakova G, Andoskin P, et al
    Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.
    Neurosci Lett. 2016 Oct 22. pii: S0304-3940(16)30792.
    PubMed     Abstract available


  246. ABREU GM, Valenca DC, Campos M Junior, da Silva CP, et al
    Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Neurosci Lett. 2016;635:67-70.
    PubMed     Abstract available


  247. DENG X, Tang CY, Zhang J, Zhu L, et al
    The cortical thickness correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Neurosci Lett. 2016;633:279-289.
    PubMed     Abstract available


  248. HOU Y, Luo C, Yang J, Song W, et al
    A resting-state fMRI study on early-stage drug-naive Parkinson's disease patients with drooling.
    Neurosci Lett. 2016 Oct 4. pii: S0304-3940(16)30749.
    PubMed     Abstract available


    September 2016
  249. ZENG W, Liu F, Wang Q, Wang Y, et al
    Parkinson's disease classification using gait analysis via deterministic learning.
    Neurosci Lett. 2016 Sep 27. pii: S0304-3940(16)30726.
    PubMed     Abstract available


  250. SHI C, Li F, Yang J, Zhang S, et al
    DNAJC6 mutations are not common causes of early onset Parkinson's disease in Chinese Han population.
    Neurosci Lett. 2016 Sep 26. pii: S0304-3940(16)30727.
    PubMed     Abstract available


  251. DENG X, Li FJ, Tang CY, Zhang J, et al
    The cortical surface correlates of clinical manifestations in the mid-stage sporadic Parkinson's disease.
    Neurosci Lett. 2016 Sep 17. pii: S0304-3940(16)30707.
    PubMed     Abstract available


  252. MATSUURA K, Maeda M, Tabei KI, Umino M, et al
    A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson's disease.
    Neurosci Lett. 2016 Sep 9. pii: S0304-3940(16)30684.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: